What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
Lymphoma, Pathology, Internal medicine, MALT lymphoma and Helicobacter pylori are his primary areas of study.
His studies in Lymphoma integrate themes in fields like Marginal zone and Gastric mucosa.
His Pathology research incorporates elements of Gene rearrangement and B cell.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Surgery and Oncology.
His research in Gastroenterology intersects with topics in Oxaliplatin and Capecitabine.
His Lymphatic system research is multidisciplinary, incorporating elements of Stomach and Antibody.
His most cited work include:
- Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori (1852 citations)
- Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma (1581 citations)
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial (491 citations)
What are the main themes of his work throughout his whole career to date?
Andrew Wotherspoon spends much of his time researching Pathology, Internal medicine, Lymphoma, Oncology and Colorectal cancer.
His Pathology research includes themes of Gene rearrangement, Immunophenotyping and B cell.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Surgery.
He has included themes like Helicobacter pylori and Lymphatic system in his Lymphoma study.
He has researched Lymphatic system in several fields, including Stomach and Gastric mucosa.
In Oncology, Andrew Wotherspoon works on issues like Epirubicin, which are connected to Panitumumab.
He most often published in these fields:
- Pathology (42.14%)
- Internal medicine (38.21%)
- Lymphoma (37.86%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (38.21%)
- Oncology (23.57%)
- Cancer (9.29%)
In recent papers he was focusing on the following fields of study:
Andrew Wotherspoon mainly focuses on Internal medicine, Oncology, Cancer, Cancer research and Pathology.
His Oncology research incorporates themes from Chemotherapy, High grade B-cell lymphoma, Meta-analysis, Retrospective review and Adenocarcinoma.
His biological study spans a wide range of topics, including Clinical trial and Progression-free survival.
His Cancer research research includes elements of Colorectal cancer, Single-nucleotide polymorphism, Gene and Immune system.
His research on Pathology frequently connects to adjacent areas such as Relapsed Angioimmunoblastic T-cell Lymphoma.
His work deals with themes such as Peripheral and Amyloidosis, which intersect with Lymphoma.
Between 2017 and 2021, his most popular works were:
- Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer. (64 citations)
- Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer (56 citations)
- KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer. (30 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
His primary areas of study are Internal medicine, Oncology, Colorectal cancer, Cancer research and Cetuximab.
Much of his study explores Internal medicine relationship to Gastroenterology.
His Oncology study also includes fields such as
- Chemotherapy which intersects with area such as Survival rate, Clinical trial, Rituximab and Lymph,
- Cancer, which have a strong connection to Retrospective cohort study, Biopsy, Lymphoma, Mature B-Cell Non-Hodgkin's Lymphoma and Lung cancer.
His Colorectal cancer research is multidisciplinary, incorporating perspectives in Proportional hazards model, Primary tumor, Tumor Regression Grade and Digital polymerase chain reaction.
Andrew Wotherspoon interconnects Immune checkpoint, ALK-Positive, Lorlatinib and Transformation in the investigation of issues within Cancer research.
The various areas that Andrew Wotherspoon examines in his Cetuximab study include Biomarker, KRAS, Immune system and Gene mutation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
